Menu
Recruiting NCT05465538

SV2A in Older Adults

Phase I / Phase II Interventional Cannabis Use

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: [11C]UCB-J PET.
Who it may be relevant to
Registry conditions: Cannabis Use. Basic parameters: from 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effect of Cannabis Use on Synaptic Density in Older Adults

Overview

The aim of the study is to examine the effect of cannabis use on brain synaptic density among older adults using \[11C\]UCB-J PET imaging.

Interventions

  • Drug [11C]UCB-J PET
    Single PET scan using the radioligand \[11C\]UCB-J

Primary outcome measures

  • Hippocampal synaptic density [Time frame: 1 month]

Eligibility criteria

Inclusion criteria

  • Able to provide informed consent
  • Male or female, aged ≥50 years
  • No history of significant medical or neurological disease
  • BMI ≤ 50
  • If woman of childbearing potential, must agree to use an acceptable method of birth control, as determined by the principal investigator, for the duration of the study and up to one month after completion of PET scans

Exclusion criteria

  • Women with a positive pregnancy test or women who are lactating
  • Have had exposure to ionizing radiation that in combination with the study tracer would result in a cumulative exposure that exceeds recommended exposure limits;
  • History of a bleeding disorder or are currently taking anticoagulants
  • Subjects who have donated blood within 8 weeks of the present study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Other

Study locations

United States · 1 center
  • Conneticut Mental Health Center — New Haven

Identifiers

NCT: NCT05465538 · 2000032183

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗